State Street Corp Evelo Biosciences, Inc. Transaction History

State Street Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.44 - $48.2 $55,110 - $1.84 Million	38,271 Added 33.61%	152,129 $244,000
Q3 2022 Nov 15, 2022	BUY	$1.86 - $41.8 $36,642 - $823,460	19,700 Added 20.92%	113,858 $238,000
Q2 2022 Aug 15, 2022	SELL	$1.46 - $3.55 $707,666 - $1.72 Million	-484,703 Reduced 83.73%	94,158 $199,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.63 $49,127 - $122,449	18,469 Added 3.3%	578,861 $1.96 Million
Q4 2021 Feb 14, 2022	BUY	$6.07 - $12.0 $133,837 - $264,588	22,049 Added 4.1%	560,392 $3.4 Million
Q3 2021 Nov 15, 2021	BUY	$6.79 - $13.9 $329,735 - $675,011	48,562 Added 9.92%	538,343 $3.79 Million
Q2 2021 Aug 16, 2021	BUY	$9.43 - $16.6 $1.59 Million - $2.79 Million	168,263 Added 52.33%	489,781 $6.73 Million
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $263,704 - $505,138	27,158 Added 9.23%	321,518 $3.44 Million
Q4 2020 Feb 16, 2021	BUY	$3.91 - $12.28 $127,333 - $399,910	32,566 Added 12.44%	294,360 $3.56 Million
Q3 2020 Nov 10, 2020	BUY	$3.81 - $5.73 $118,822 - $178,701	31,187 Added 13.52%	261,794 $1.38 Million
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.12 $2,195 - $3,806	622 Added 0.27%	230,607 $1.13 Million
Q1 2020 May 11, 2020	BUY	$3.21 - $7.06 $738,251 - $1.62 Million	229,985 New	229,985 $864,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.